RecruitingSquamous Cell CarcinomaNonmelanoma Skin CancerCutaneous Squamous Cell Carcinoma
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to research if a type of biopsy known as sentinel lymph node biopsy (SLNB) can help in determining the rate of tumor deposits that are hard to detect and identify in node-negative cutaneous squamous cell carcinoma of the head or neck.
Sponsor: Indiana University
You may qualify if…
- ✓ Patients ≥ 18 years old at the time of informed consent
- ✓ Ability to provide written informed consent and HIPAA authorization
- ✓ Primary or recurrent invasive cutaneous squamous cell carcinoma of the head or neck, clinically staged T2-T4 based on AJCC staging
- ✓ Clinically and radiographically regional node-negative (no evidence of regional lymph node metastasis or distant metastasis)
- ✓ Able to undergo general anesthesia for sentinel lymph node biopsy
- ✓ Able to undergo CT scan with contrast or MRI with contrast
- ✓ Undergo surgical resection (Moh's or micrographic resection or standard excision with sentinel lymph node biopsy) within 8 weeks of imaging
You may not qualify if…
- ✕ Clinical evidence of satellite lesions, in-transit, regional nodal or distant metastases
- ✕ Known biopsy proven synchronous primary cutaneous squamous cell carcinoma
- ✕ Pregnant patients
- ✕ Patients unable to undergo general anesthesia
- ✕ Patient unable to receive contrasted imaging studies
- ✕ Patient unable to receive and/or allergic to 99m-Technetium sulfur colloid
Where it's recruiting
Indiana
Indianapolis
Source: ClinicalTrials.gov · NCT05108090 · last updated 2025-06-11